|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,710 KRW | +0.22% |
|
-1.01% | -12.40% |
Ilyang Pharmaceutical Co.,Ltd reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 0.00024 million compared to negative sales of KRW 0.00046 million a year ago. Net income was KRW 2,914.66 million compared to KRW 6,025 million a year ago.
Basic earnings per share from continuing operations was KRW 161 compared to KRW 331 a year ago. Basic earnings per share was KRW 161 compared to KRW 331 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -12.40% | 179M | |
| +19.62% | 43.34B | |
| +20.44% | 21.96B | |
| +10.86% | 14.09B | |
| +13.07% | 13.64B | |
| +37.46% | 11.43B | |
| -8.59% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +8.46% | 5.22B |
ILYANG PHARMACEUTICAL CO.,LTD 
